Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-on observational study of VIB4920 in moderate to severe rheumatoid arthritis
2019-002351-42Phase 3Completed
- Sponsor
- Viela Bio
- Start
- Nov 2019
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of dazodalibep in rheumatoid arthritis (RA), sponsored by Viela Bio. Started Nov 2019; status: completed.
02
Drugs
dazodalibep
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2019-002351-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002351-42.